Topic: drug shortage

Here is some other vaccine news of note for the week.

Experts say China's data sharing rule may hinder drug R&D; FDA rejects Mylan and Biocon's Lantus biosim and more news.

When Roche got Herceptin onto China’s insurance list, it didn’t expect demand to surge so fast. Now, it's shifting to a new plant to boost supplies.

Pfizer, which has struggled with manufacturing issues that have kept it from producing essential injected narcotics, says shipments have resumed.

Manufacturing problems have created a shortage of Mylan’s EpiPens in Britain, forcing the company to ration the lifesaving injection devices.

Amid the opioid crisis in the U.S., physicians and hospital pharmacists are having increasing difficulty finding injectable painkillers.

Jazz Pharmaceuticals has released new vials of Erwinaze, its leukemia drug for children, that came into short supply in 2016.

Power has been restored to three Baxter International plants in Puerto Rico, meaning production of saline solution and amino acids is increasing.

Already dealing with a saline shortage, the FDA now says IV feeding products are scarce after the hurricane damaged plants in Puerto Rico.

With a U.S. saline shortage intensifying, the FDA is getting Baxter preferential treatment in having power restored to saline plants in Puerto Rico.